1.17
Talphera Inc stock is traded at $1.17, with a volume of 359.72K.
It is down -4.88% in the last 24 hours and up +24.47% over the past month.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$1.23
Open:
$1.26
24h Volume:
359.72K
Relative Volume:
0.14
Market Cap:
$24.01M
Revenue:
$2.82M
Net Income/Loss:
$-14.20M
P/E Ratio:
-1.3765
EPS:
-0.85
Net Cash Flow:
$-15.13M
1W Performance:
+6.36%
1M Performance:
+24.47%
6M Performance:
+134.00%
1Y Performance:
+48.10%
Talphera Inc Stock (TLPH) Company Profile
Compare TLPH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TLPH
Talphera Inc
|
1.17 | 56.07M | 2.82M | -14.20M | -15.13M | -0.85 |
![]()
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
![]()
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
![]()
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
Jul-20-20 | Downgrade | Credit Suisse | Neutral → Underperform |
Nov-11-19 | Downgrade | Credit Suisse | Outperform → Neutral |
Aug-05-19 | Resumed | Credit Suisse | Outperform |
Jul-10-19 | Resumed | Credit Suisse | Outperform |
Apr-24-19 | Resumed | B. Riley FBR | Buy |
Feb-15-19 | Initiated | Credit Suisse | Outperform |
Oct-23-18 | Initiated | B. Riley FBR | Buy |
Oct-13-17 | Downgrade | Jefferies | Buy → Hold |
Oct-13-17 | Reiterated | RBC Capital Mkts | Outperform |
Jul-14-17 | Resumed | Jefferies | Buy |
Sep-15-16 | Reiterated | ROTH Capital | Buy |
Aug-05-16 | Downgrade | Stifel | Buy → Hold |
Oct-30-15 | Upgrade | Jefferies | Hold → Buy |
Oct-05-15 | Reiterated | ROTH Capital | Buy |
Sep-02-15 | Initiated | H.C. Wainwright | Buy |
Jul-10-15 | Resumed | ROTH Capital | Buy |
May-06-15 | Reiterated | Mizuho | Neutral |
May-05-15 | Reiterated | RBC Capital Mkts | Outperform |
Mar-10-15 | Reiterated | RBC Capital Mkts | Outperform |
Mar-09-15 | Downgrade | Mizuho | Buy → Neutral |
View All
Talphera Inc Stock (TLPH) Latest News
Regression analysis insights on Talphera Inc. performancePortfolio Update Summary & Low Risk High Reward Trade Ideas - newser.com
Analyzing Talphera Inc. with multi timeframe chartsTreasury Yields & Fast Entry High Yield Stock Tips - newser.com
Why Talphera Inc. stock appeals to analystsJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com
Can volume confirm reversal in Talphera Inc.July 2025 Rallies & Comprehensive Market Scan Reports - newser.com
Why Talphera Inc. is moving todayJuly 2025 Recap & Community Verified Trade Signals - newser.com
Talphera (NASDAQ:TLPH) Trading Down 3.1% – Here’s Why - Defense World
Talphera’s (TLPH) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
Is Talphera Inc. (R5XA) stock a good hedge against inflationWeekly Trend Summary & Safe Capital Growth Plans - newser.com
What momentum shifts mean for Talphera Inc.2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
How sustainable is Talphera Inc. stock dividend payout2025 Market Trends & High Accuracy Buy Signal Tips - newser.com
Is Talphera Inc. a candidate for recovery playJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com
How Talphera Inc. (R5XA) stock compares with market leadersMarket Volume Summary & Free Verified High Yield Trade Plans - newser.com
Talphera (NASDAQ:TLPH) and Xeris Biopharma (NASDAQ:XERS) Head-To-Head Contrast - Defense World
Sector ETF performance correlation with Talphera Inc.Layoff News & Daily Growth Stock Investment Tips - newser.com
Is this a good reentry point in Talphera Inc.Market Performance Report & AI Powered Market Entry Strategies - newser.com
Talphera Inc R5XA Stock Analysis and ForecastCapital Gains Strategies & Low Risk Wealth Building - earlytimes.in
What analysts say about Talphera Inc stockTrading Volume Surges & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Is Talphera Inc. stock supported by strong fundamentalsJobs Report & Verified Momentum Stock Ideas - newser.com
How strong dollar benefits Talphera Inc. (R5XA) stockJuly 2025 PreEarnings & Risk Controlled Daily Trade Plans - newser.com
Statistical indicators supporting Talphera Inc.’s strengthWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Using Bollinger Bands to evaluate Talphera Inc.Trade Volume Summary & High Win Rate Trade Alerts - newser.com
Talphera, Inc. (NASDAQ:TLPH) Short Interest Update - Defense World
Is Talphera Inc. stock poised for growth2025 Short Interest & Target Return Focused Stock Picks - newser.com
How Talphera Inc. stock performs in rising dollar environmentWeekly Market Summary & Real-Time Price Movement Reports - newser.com
What the charts say about Talphera Inc. todayWeekly Earnings Recap & Real-Time Market Sentiment Alerts - newser.com
Can Talphera Inc. stock resist sector downturnsJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
Short interest data insights for Talphera Inc.Index Update & Consistent Growth Equity Picks - newser.com
9th Circ. Ruling May Help Pharma Cos. Avert Investor Claims - Law360
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Talphera Inc Stock (TLPH) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Dec 05 '24 |
Buy |
0.64 |
5,000 |
3,200 |
208,066 |
ASADORIAN RAFFI | Chief Financial Officer |
Dec 02 '24 |
Sale |
0.77 |
155 |
119 |
37,578 |
Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Nov 27 '24 |
Buy |
0.73 |
5,000 |
3,650 |
203,066 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):